Advertisement
Screener

TELA Bio, Inc. (TELA) Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four

2.5 / 5 stars · 33/66 Roast Me

TELA Bio, Inc. Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four

TELA Bio, Inc. (TELA) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $377.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-11.

Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2022-05-11

  • 2022-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $377.00K.
  • 2021-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $400.00K.
Period endLessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
2022-03-31$377.00K
10-Q · filed 2022-05-11
2021-12-31$400.00K
10-Q · filed 2022-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
InspireMD, Inc. (NSPR)$0.033B